Skip to content

Management of Prelabor Rupture of the Membranes at Term

Comparison Between Two Protocols for Management of Prelabor Rupture of the Membranes at Term

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04307069
Enrollment
524
Registered
2020-03-13
Start date
2020-05-01
Completion date
2024-05-01
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Chorioamnionitis, Endometritis, Fetal Infection

Brief summary

Prolonged rupture of membranes has been associated with increased risk of chorioamnionitis and endometritis. In this study the investigators will investigate whether an early intervention to augment labor with oxytocin is superior to expected management for spontaneous delivery (up to 24 hours).

Detailed description

Prelabor rupture of the membranes (PROM) refers to rupture of the fetal membranes prior to the onset of regular uterine contractions. PROM at term can be managed actively by induction of labor or expectantly by waiting for the onset of a spontaneous labor. Several studies have shown an association between expectant management and higher rates of maternal and neonatal adverse outcomes, especially infections. Furthermore, expectant management has been shown to increase the risk for cesarean deliveries (CD), chronic lung disease, cerebral palsy and neonatal mortality. It is suggested that the risk for those complications increase proportionally with the longer the duration of ruptured membranes. Others disagree with those associations. In this study the investigators will investigate whether early administration of oxytocin is superior to expectant management of 24 hours in patients with PROM at term, in terms of time to delivery and maternal and neonatal adverse outcomes, regardless of bishop score.

Interventions

DRUGOxytocin

The drug wil be adminisrate for augmentation of labor at admission.

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Primiparous women with a singleton pregnancy that are admitted with prelabor rupture of membranes. 2. Women at gestational age 370/7 or more. 3. Vertex presentation.

Exclusion criteria

1. Age 18 and under. 2. High order gestation. 3. Women with contraindication for a vaginal delivery. 4. Active labor. 5. Documented fetal anomalies. 6. Known or suspected intrauterine infection (temperature \> 38 degrees, leucocytosis). 7. Non reassuring fetal heart rate tracing. 8. Positive group B streptococcus status.

Design outcomes

Primary

MeasureTime frameDescription
Maternal infectious morbidityUp to 48 hours postpartumMaternal chorioamnionitis and/ or endometritis

Secondary

MeasureTime frameDescription
Length of latent and active phases of labor.During LaborAccording to vaginal examinations during labor
Adverse maternal outcomeUp to 48 hours postpartuminfectious (chorioamnionitis/endometritis), serious maternal morbidity and mortality (death, cardiac arrest, respiratory arrest, ICU admission), post-partum hemorrhage (PPH), obstetric anal sphincter injuries (OASIS).
Adverse neonatal outcomeUp to 48 hours postpartumstillbirth, infectious disease (sepsis, meningitis, pneumonia), 5-minute Apgar score \< 7, umbilical artery pH \< 7.0, NICU admission, RDS, use of mechanical ventilation, NEC.

Countries

Israel

Contacts

Primary ContactGal Bachar, MD
gal.bachar13@gmail.com+972524858699

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026